Antonio Henriques is Co-Founder and Chief Executive Officer of Momentum Therapeutics, a biotechnology company developing therapies to preserve neuronal connectivity and address age-associated neurodegenerative conditions. He brings more than 15 years of experience in the pharmaceutical and biotech industries, with senior leadership roles in business development, commercial strategy, and innovation across global companies including Amgen, Genentech, and Sanofi. Antonio’s career spans Europe, Latin America, and the United States, where he has contributed to major licensing deals, strategic launches, and multi-billion-dollar transactions across neurology, oncology, inflammation, rare diseases, and vaccines. He also co-founded the Brazilian-American Life Sciences Association to foster cross-border collaboration in life sciences. Antonio holds a BS in Biology from Universidade Federal de Minas Gerais, an MA in Economics from the Barcelona Graduate School of Economics, and an MBA from Harvard Business School.